| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.064 | 0.7 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.12 | 0.7 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.045 | 0.7 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |